Marianna Torok

Find an error

Name: Marianna Török
Organization: University of Massachusetts Boston
Department: Department of Chemistry
Title:
Co-reporter:Swarada Peerannawar;William Horton;Anne Kokel;Fanni Török
Structural Chemistry 2017 Volume 28( Issue 2) pp:391-402
Publication Date(Web):2017 April
DOI:10.1007/s11224-016-0867-x
Structural and energetic features of a series of 15 diarylhydrazone derivatives were studied via density functional theory (DFT) in order to identify the key features that most likely contribute to their antioxidant effect. Theoretical calculations were carried out at the B3LYP/6-31G(d,p) level. The calculated physicochemical parameters included the ionization potential, N-H dissociation enthalpy, proton affinity, HOMO/LUMO energies, and the band gaps of the most stable conformation of the compounds. To assess the contribution of these factors to the in vitro activity, the compounds were synthesized and their antioxidant activity was also determined in three commonly used assays. The hydrazones were evaluated for their radical scavenging against the 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2′-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS), and peroxyl (ORAC assay) radicals. The experimental radical scavenging data of the compounds have been then plotted against the physicochemical characteristics and based on the obtained fits conclusions have been drawn regarding the relative importance of the respective factors.
Co-reporter:Seema Bag, Rekha Tulsan, Abha Sood, Hyejin Cho, Hana Redjeb, Weihong Zhou, Harry LeVine III, Béla Török, Marianna Török
Bioorganic & Medicinal Chemistry Letters 2015 Volume 25(Issue 3) pp:626-630
Publication Date(Web):1 February 2015
DOI:10.1016/j.bmcl.2014.12.006
Sulfonamide linker-based inhibitors with extended linear structure were designed and synthesized with the aim of producing multifunctional agents against several processes involved in the pathology of Alzheimer’s disease (AD). The potency of the compounds were assessed in the inhibition of Aβ self-assembly (fibril and oligomer formation), in modulating cholinesterase (AChE, BuChE) activity, and scavenging free radicals. Several compounds exhibited promising Aβ self-assembly and cholinesterase inhibition and in parallel, showed good free radical scavenging properties. The investigation of the scaffold described in this study resulted in the identification of three compounds (14, 19 and 26) as promising leads for the further design of multifunctional drug candidates for AD.
Co-reporter:Béla Török, Abha Sood, Seema Bag, Rekha Tulsan, Sanjukta Ghosh, Dmitry Borkin, Arleen R. Kennedy, Michelle Melanson, Richard Madden, Weihong Zhou, Harry LeVine III, and Marianna Török
Biochemistry 2013 Volume 52(Issue 7) pp:
Publication Date(Web):January 24, 2013
DOI:10.1021/bi3012059
The design and application of an effective, new class of multifunctional small molecule inhibitors of amyloid self-assembly are described. Several compounds based on the diaryl hydrazone scaffold were designed. Forty-four substituted derivatives of this core structure were synthesized using a variety of benzaldehydes and phenylhydrazines and characterized. The inhibitor candidates were evaluated in multiple assays, including the inhibition of amyloid β (Aβ) fibrillogenesis and oligomer formation and the reverse processes, the disassembly of preformed fibrils and oligomers. Because the structure of the hydrazone-based inhibitors mimics the redox features of the antioxidant resveratrol, the radical scavenging effect of the compounds was evaluated by colorimetric assays against 2,2-diphenyl-1-picrylhydrazyl and superoxide radicals. The hydrazone scaffold was active in all of the different assays. The structure–activity relationship revealed that the substituents on the aromatic rings had a considerable effect on the overall activity of the compounds. The inhibitors showed strong activity in fibrillogenesis inhibition and disassembly, and even greater potency in the inhibition of oligomer formation and oligomer disassembly. Supporting the quantitative fluorometric and colorimetric assays, size exclusion chromatographic studies indicated that the best compounds practically eliminated or substantially inhibited the formation of soluble, aggregated Aβ species, as well. Atomic force microscopy was also applied to monitor the morphology of Aβ deposits. The compounds also possessed the predicted antioxidant properties; approximately 30% of the synthesized compounds showed a radical scavenging effect equal to or better than that of resveratrol or ascorbic acid.
Co-reporter:Seema Bag, Sanjukta Ghosh, Rekha Tulsan, Abha Sood, Weihong Zhou, Christine Schifone, Michelle Foster, Harry LeVine III, Béla Török, Marianna Török
Bioorganic & Medicinal Chemistry Letters 2013 Volume 23(Issue 9) pp:2614-2618
Publication Date(Web):1 May 2013
DOI:10.1016/j.bmcl.2013.02.103
A series of compounds containing an α,β-unsaturated carbonyl moiety, such as chalcones and coumarins were designed, synthesized and tested in a variety of assays to assess their potential as anti-Alzheimer’s disease (AD) agents. The investigations included the inhibition of cholinesterases (AChE, BuChE), the inhibition of amyloid beta (Aβ) self-assembly and the disassembly of preformed Aβ oligomers. Several compounds showed excellent potential as multifunctional compounds for AD. Docking studies for 16 that performed well in all the assays gave a clear interpretation of various interactions in the gorge of AChE. Based on the results, the long-chain coumarin scaffold appears to be a promising structural template for further AD drug development.
Co-reporter:Michelle Melanson;Abha Sood;Fanni Török ;Marianna Török
Biochemistry and Molecular Biology Education 2013 Volume 41( Issue 3) pp:156-162
Publication Date(Web):
DOI:10.1002/bmb.20677

An undergraduate laboratory exercise is described to demonstrate the biochemical applications of electron paramagnetic resonance (EPR) spectroscopy. The β93 cysteine residue of hemoglobin is labeled by the covalent binding of 3-maleimido-proxyl (5-MSL) and 2,2,5,5-tetramethyl-1-oxyl-3-methyl methanethiosulfonate (MTSL), respectively. The excess spin label is removed by gel-exclusion chromatography. Changes in the mobility of the reporter groups attached to the protein are monitored by EPR spectroscopy. While the spectral parameters of the rigidly attached 5-MSL provide information on the rotation of the whole spin labeled protein, MTSL bound by a more flexible linkage describes the local environment of the cysteine residue in the interior of the protein structure. Students can study the known crystal structure of hemoglobin in comparison to the results they obtain by analyzing the EPR spectra. Overall, the exercise introduces them to laboratory techniques such as protein labeling, gel filtration, EPR spectroscopy, as well as familiarizes them with the online Protein Data Bank as a research resource and PyMOL software as a structure visualization tool. © 2013 by The International Union of Biochemistry and Molecular Biology, 41(3):156–162, 2013

Co-reporter: Béla Török;Abha Sood;Dr. Seema Bag;Dr. Aditya Kulkarni;Dr. Dmitry Borkin;Elizabeth Lawler;Dr. Sujaya Dasgupta;Dr. Shainaz Lge; Mohammed Abid;Weihong Zhou; Michelle Foster; Harry LeVine III; Marianna Török
ChemMedChem 2012 Volume 7( Issue 5) pp:910-919
Publication Date(Web):
DOI:10.1002/cmdc.201100569

Abstract

A broad group of structurally diverse small organofluorine compounds were synthesized and evaluated as inhibitors of β-amyloid (Aβ) self-assembly. The main goal was to generate a diverse library of compounds with the same functional group and to observe general structural features that characterize inhibitors of Aβ oligomer and fibril formation, ultimately identifying structures for further focused inhibitor design. The common structural motifs in these compounds are CF3-C-OH and CF3-C-NH groups that were proposed to be binding units in our previous studies. A broad range of potential small-molecule inhibitors were synthesized by combining various carbocyclic and heteroaromatic rings with an array of substituents, generating a total of 106 molecules. The compounds were tested by standard methods such as thioflavin-T fluorescence spectroscopy for monitoring fibril formation, biotinyl Aβ1–42 single-site streptavidin-based assays for observing oligomer formation, and atomic force microscopy for morphological studies. These assays revealed a number of structures that show significant inhibition against either Aβ fibril or oligomer formation. A detailed analysis of the structure–activity relationship of anti-fibril and -oligomer properties is provided. These data present further experimental evidence for the distinct nature of fibril versus oligomer formation and indicate that the interaction of the Aβ peptide with chiral small molecules is not stereospecific in nature.

Co-reporter:Abha Sood, Mohammed Abid, Catharine Sauer, Samson Hailemichael, Michelle Foster, Béla Török, Marianna Török
Bioorganic & Medicinal Chemistry Letters 2011 Volume 21(Issue 7) pp:2044-2047
Publication Date(Web):1 April 2011
DOI:10.1016/j.bmcl.2011.02.012
A potential therapeutic approach for Alzheimer’s disease is to reduce the amount of toxic amyloid-beta oligomers and fibrillar amyloid plaques. In order to contribute to this approach the ability of small organofluorine compounds that were previously reported as successful inhibitors of fibrillogenesis to destabilize preformed fibrils of the amyloid-beta peptide was studied. These organofluorine molecules including chiral compounds were tested in vitro using standard methods based on Thioflavin-T (THT) fluorescence spectroscopy, atomic force microscopy (AFM) and Fourier-transform infrared spectroscopy (FTIR). It was observed that 5′-halogen substituted 3,3,3-trifluoromethyl-2-hydroxyl-(indol-3-yl)-propionic acid esters showed significant activity in the disassembly of the preformed fibrils. Since the same compounds were identified as strong fibrillogenesis inhibitors as well, this dual action makes them promising candidates for further drug development.
Co-reporter:Aleksra Rudnitskaya;Béla Török ;Marianna Török
Biochemistry and Molecular Biology Education 2010 Volume 38( Issue 4) pp:261-265
Publication Date(Web):
DOI:10.1002/bmb.20392

Abstract

Molecular docking is a frequently used method in structure-based rational drug design. It is used for evaluating the complex formation of small ligands with large biomolecules, predicting the strength of the bonding forces and finding the best geometrical arrangements. The major goal of this advanced undergraduate biochemistry laboratory exercise is to illustrate the importance and application of this tool. Students carry out the computational modeling of the interaction of acetylcholinesterase and its inhibitor, tacrine, and learn about the concepts of protein structure, enzyme-inhibitor interactions, intermolecular forces, and role of molecular design in drug-development.

Co-reporter:Abha Sood, Mohammed Abid, Samson Hailemichael, Michelle Foster, Béla Török, Marianna Török
Bioorganic & Medicinal Chemistry Letters 2009 Volume 19(Issue 24) pp:6931-6934
Publication Date(Web):15 December 2009
DOI:10.1016/j.bmcl.2009.10.066
The effect of enantiomeric trifluoromethyl-indolyl-acetic acid ethyl esters on the fibrillogenesis of Alzheimer’s amyloid β (Aβ) peptide is described. These compounds have been previously identified as effective inhibitors of the Aβ self-assembly in their racemic form. Thioflavin-T Fluorescence Spectroscopy and Atomic Force Microscopy were applied to assess the potency of the chiral target compounds. Both enantiomers showed significant inhibition in the in vitro assays. The potency of the enantiomeric inhibitors appeared to be very similar to each other suggesting the lack of the stereospecific binding interactions between these small molecule inhibitors and the Aβ peptide.
Co-reporter:William Horton, Abha Sood, Swarada Peerannawar, Nandor Kugyela, Aditya Kulkarni, Rekha Tulsan, Chris D. Tran, Jessica Soule, Harry LeVine III, Béla Török, Marianna Török
Bioorganic & Medicinal Chemistry Letters (15 January 2017) Volume 27(Issue 2) pp:
Publication Date(Web):15 January 2017
DOI:10.1016/j.bmcl.2016.11.067
The design, synthesis and assessment of β-carboline core-based compounds as potential multifunctional agents against several processes that are believed to play a significant role in Alzheimer’s disease (AD) pathology, are described. The activity of the compounds was determined in Aβ self-assembly (fibril and oligomer formation) and cholinesterase (AChE, BuChE) activity inhibition, and their antioxidant properties were also assessed. To obtain insight into the mode of action of the compounds, HR-MS studies were carried out on the inhibitor-Aβ complex formation and molecular docking was performed on inhibitor-BuChE interactions. While several compounds exhibited strong activities in individual assays, compound 14 emerged as a promising multi-target lead for the further structure-activity relationship studies.
1,2-Benzisothiazol-3(2H)-one, 2-(3-bromopropyl)-, 1,1-dioxide
Benzenemethanol, a-[1-(methylamino)ethyl]-
Cyclohexanone, 3,3,5-trimethyl-, (5S)-
Cyclohexanone, 3,3,5-trimethyl-, (5R)-
(HYDROXYMETHYLAMINO)METHANOL
2-(2-hydroxyethyl)-1,1-dioxo-1,2-benzothiazol-3-one
2-BROMO-N,N-DIETHYLETHYLAMINE HYDROBROMIDE
N'-NAPHTHALEN-1-YLETHANE-1,2-DIAMINE